Steven Cress talks to Kim Khan about his top dividend stocks for the year. Diversification and strong fundamentals are key strategies for investors.
The consumer staples sector has struggled due to rising costs, e-commerce, and consumer resistance to price hikes, lagging significantly behind the S&P 500. The Clorox Company might seem like an opportunity, but its shares are expensive compared to other staples names. Clorox faces the same long-term issues as the sector, such as margin compression and competition from store brands.
CLX is poised for growth as its IGNITE Strategy drives innovation, efficiency and international expansion amid a challenging market.
CLX looks poised for growth through recent recovery, improved distribution channels and focus on innovation and expansion despite facing some cost challenges.
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Consumer staple stocks like CLX, MO, OLLI and TSN are a safe bet during times of market volatility.
Consumer staples behemoth Clorox (CLX 0.58%) has faced no shortage of issues over the last few years. With ballooning inflation and a cyberattack hampering Clorox's operations (among many other companies), the company's stock still languishes 33% below its all-time highs from 2020.
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Here is how Clorox (CLX) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.
Consumer staple stocks like TSN, UNFI, INGR and CLX that belong to the defensive space are a safe bet during times of market volatility.